Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ipsen
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Adult men diagnosed of locally advanced or metastatic prostate cancer scheduled to receive androgen deprivation therapy with a 3 or 6 month LHRH analogue including those requiring neo-adjuvant or adjuvant androgen deprivation therapy in association with radiotherapy
Patients having provided written informed consent
Patients mentally fit for completing a self-administrated questionnaire
You may not be if
Patients participating in another clinical study at the time of inclusion
Patients with another severe malignant disease
Life expectancy of less than 12 months
Patients already treated with a LHRH analogue within the last year
